An HLA-Presented Fragment of Macrophage Migration Inhibitory Factor Is a Therapeutic Target for Invasive Breast Cancer-Reference-Cited by-同舟云学术

An HLA-Presented Fragment of Macrophage Migration Inhibitory Factor Is a Therapeutic Target for Invasive Breast Cancer

Published:2011-04-22 Issue:11 Volume:186 Page:6607-6616
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Hawkins Oriana,Verma Bhavna,Lightfoot Stanley,Jain Rinki,Rawat Amit,McNair Sandy,Caseltine Shannon,Mojsilovic Aleksandar,Gupta Priyanka,Neethling Francisca,Almanza Othon,Dooley William,Hildebrand William,Weidanz Jon

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer

2. Producing Nature’s Gene-Chips: The Generation of Peptides for Display by MHC Class I Molecules

3. Antigen processing and presentation

4. Specific T cell recognition of peptides derived from prostate-specific antigen in patients with prostate cancer;Alexander;Urology,1998

5. Derivation of tumor-specific cytolytic T-cell clones from two lung cancer patients with long survival;Weynants;Am. J. Respir. Crit. Care Med.,1999

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy;Molecular Cancer Therapeutics;2021-06-25

2. A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer;OncoImmunology;2019-11-29

3. TCR-like antibodies in cancer immunotherapy;Journal of Hematology & Oncology;2019-09-14

4. Targeting the MHC Ligandome by Use of TCR-Like Antibodies;Antibodies;2019-05-09

5. Opportunities and Challenges for Antibodies against Intracellular Antigens;Theranostics;2019